KR

Kadiri Ravi Kishore

Active Director Director DIN 10394749
DIN 10394749 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Kadiri Ravi Kishore

Data last updated:

Kadiri Ravi Kishore is a Director at Svl Bioscience Private Limited (since 2023). Svl Bioscience Private Limited reported revenue of ₹1,000 (FY 2025).

DIN 10394749
Primary Designation Director
First Appointment 17 Nov 2023
Oldest Company Age 2 yrs
Largest company Svl Bioscience Private Limited · ₹1,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Svl Bioscience Private Limited U86201AP2023PTC112971
Director17 Nov 20232023₹1,000 (FY 2025)Active

Board colleagues of Kadiri Ravi Kishore

NameDINCompanyDesignation
Govindamma Gade10394748Svl Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Svl Bioscience Private Limited
Premium access

Shareholding and investment profile for Kadiri Ravi Kishore

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kadiri Ravi Kishore

Kadiri Ravi Kishore currently holds 1 directorship: Svl Bioscience Private Limited (Director, since 17 Nov 2023, revenue ₹1,000 (FY 2025)).

Kadiri Ravi Kishore was first appointed on 17 Nov 2023 as Director at Svl Bioscience Private Limited.

The current boards of Kadiri Ravi Kishore's companies include Govindamma Gade (Svl Bioscience Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available